Managing Editor
@ShahidNShah
@ShahidNShah
The proprietary Carterra LSAXT HT-SPR technology platform expands beyond antibody discovery to enable PROTAC®s , protein-protein inhibitors, kinase, and cytokine screening and characterization. Enhanced sensitivity and fast data collection rate build upon unmatched capabilities in throughput and enable assays such as TPDs PROTAC®s , kinase, cytokines, DELs, and protein:protein inhibitors.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on May 21, 2025 at 12:37pm
